| Catalog Number |
03-2622-3 |
| Medical Device Problem Code |
Fluid/Blood Leak (1250)
|
| Health Effect - Clinical Code |
Hemorrhage/Blood Loss/Bleeding (1888)
|
| Date of Event |
11/07/2023
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
The plant investigation is in process.A supplemental mdr will be submitted upon completion of this activity. .
|
| |
|
Event or Problem Description
|
|
A user facility medical director reported to fresenius that a blood leak occurred during a patient's hemodialysis (hd) treatment with the combiset bloodlines.The heparin line detached from the bloodline set.The bloodlines were replaced to resolve the reported issue and complete treatment.Additional information was obtained during follow-up.The reported issue occurred approximately an hour and a half into treatment.No alarms were received from the machine (model unknown).It was not stated whether there was a change or disruption in pressure that would have caused the reported issue or triggered the machine to alarm.The patient did not experience a serious injury or require medical intervention.The patient's estimated blood loss (ebl) is approximately 50 ml.The bloodlines were replaced and treatment was restarted and successfully completed on the same machine with the same dialyzer.The sample was discarded and is not available to be returned to the manufacturer for physical evaluation.
|
| |
|
Event or Problem Description
|
|
A user facility medical director reported to fresenius that a blood leak occurred during a patient's hemodialysis (hd) treatment with the combiset bloodlines.The heparin line detached from the bloodline set.The bloodlines were replaced to resolve the reported issue and complete treatment.Additional information was obtained during follow-up.The reported issue occurred approximately an hour and a half into treatment.No alarms were received from the machine (model unknown).It was not stated whether there was a change or disruption in pressure that would have caused the reported issue or triggered the machine to alarm.The patient did not experience a serious injury or require medical intervention.The patient's estimated blood loss (ebl) is approximately 50 ml.The bloodlines were replaced and treatment was restarted and successfully completed on the same machine with the same dialyzer.The sample was discarded and is not available to be returned to the manufacturer for physical evaluation.
|
| |
|
Additional Manufacturer Narrative
|
|
Plant investigation: as the device was not returned to the manufacturer, a physical evaluation could not be performed.However a photograph was received from the customer and it was confirmed that the heparin line detached from the bloodline set.The reported event was confirmed in accordance with the picture received.A batch records review was conducted by the manufacturer for the reported lot.There were no non-conformances or abnormalities identified during the manufacturing process which could be associated with the reported event.The entire lot has been sold and distributed.In addition, a device history review was performed and confirmed that the results of the in-progress and final quality control (qc) testing met all requirements.The lot met all specifications for release.
|
| |
|
Search Alerts/Recalls
|